GANX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Gain Therapeutics reports positive Phase 1b GT-02287 results in Parkinson's diseaseDec 18, 2025
- Gain Therapeutics presents initial data from Phase 1b clinical study of GT-02287 in Parkinson's patients at International Congress of Parkinson's Disease and Movement Disorders®Oct 6, 2025
- Gain Therapeutics begins its GT-02287 Phase 1b extension study in people with Parkinson's diseaseSep 18, 2025
- Gain Therapeutics receives Australian approval of Phase 1b dosing extension and reports positive independent data monitoring committee recommendationSep 4, 2025
- Gain Therapeutics completes target enrollment in Phase 1b study of GT-02287 in Parkinson's disease patients with or without GBA1 mutationJul 1, 2025